Elsevier

Surgery

Volume 128, Issue 4, October 2000, Pages 540-547
Surgery

Central Surgical Association
Surgical shunts and tips for variceal decompression in the 1990s*,**

Presented at the 57th Annual Meeting of the Central Surgical Association, Chicago, Ill, March 2-4, 2000.
https://doi.org/10.1067/msy.2000.108209Get rights and content

Abstract

Background. In the 1990s, liver transplantations and transjugular intrahepatic portosystemic shunts (TIPS) have become the most common methods to decompress portal hypertension. This center has continued to use surgical shunts for variceal bleeding in good-risk patients who continue to bleed through endoscopic and pharmacologic treatment. This article reports this center's experience with surgical shunts and TIPS shunts from 1992 through 1999. Methods. Sixty-three patients (Child A, 43 patients; Child B, 20 patients) received surgical shunts: distal splenorenal, 54 patients; splenocaval, 4 patients; coronary caval, 1 patient; and mesocaval, 4 patients. Sixty-two patients had refractory variceal bleeding, and 1 patient had ascites with Budd-Chiari syndrome. Two hundred patients (Child A, 24 patients; Child B, 62 patients; Child C, 114 patients) received TIPS shunts. One hundred forty-nine patients had refractory variceal bleeding, and 51 patients had ascites, hydrothorax, or hepatorenal syndrome. Data were collected by prospective databases, protocol follow-up, and phone contact. Results. The 30-day mortality rate was 0% for surgical shunts and 26% for TIPS shunts; the overall survival rate was 86% (median follow-up, 36 months) for surgical shunts and 53% (median follow-up, 40 months) for TIPS shunts. For surgical shunts, the portal hypertensive rebleeding rate was 6.3%; the overall rebleeding rate was 14.3%. For TIPS shunts, the overall rebleeding rate was 25.5% (30-day, 9.4%; late, 22.4%). There were 4 reinterventions for surgical shunts (6.3%); the reintervention rate for TIPS shunts in the bleeding group was 33%, and the reintervention rate in the ascites group was 9.5%. Encephalopathy was severe in 3.1% of the shunt group and mild in 17.5%; this was not systematically evaluated in the TIPS shunts patients. Conclusions. Surgical shunts still have a role for patients whose condition was classified as Child A and B with refractory bleeding, who achieve excellent outcomes with low morbidity and mortality rates. TIPS shunts have been used in high-risk patients with significant early and late mortality rates and have been useful in the control of refractory bleeding and as a bridge to transplantation. The comparative role of TIPS shunts versus surgical shunt in patients whose condition was classified as Child A and B is under study in a randomized controlled trial. (Surgery 2000;128:540-7.)

Section snippets

Patient populations

The patient profiles for the 2 groups are summarized in Table I.Surgical shunts were performed in 73 patients from July 1992 to December 1999. Ten of these patients are excluded from this analysis because they are part of an ongoing prospective randomized controlled trial comparing distal splenorenal shunts (DSRSs) and TIPSs. Sixty-three patients are included in this analysis; 59 patients underwent selective variceal decompression, and 4 patients had total shunts. Selective shunts were 54

Patient status

The patient status is summarized for both groups in Table II.

. Status of patients in the 2 groups

Empty CellSurgical shunts (n)TIPS (n)
Patients63200
Deaths
 Early (30 day)051
 Late943
Transplantation338
In follow-up5054
Lost to follow-up114

The status of 62 of the 63 patients with surgical shunt is known; the only patient lost to follow-up was from overseas. The range of follow-up is from 1 to 80 months, with a median follow-up of 36 months. Five of the patients have not returned for follow-up visits, but their

Discussion

We report the experience at The Cleveland Clinic in the 1990s of patients who underwent decompression for portal hypertension. The groups, by design, are different and reflect this center's philosophy of providing surgical decompression for good-risk patients who have been refractory to endoscopic and pharmacologic therapy and of using TIPSs for poorer risk patients with refractory bleeding or for patients with portal hypertension and intractable ascites. A significant number of the patients

References (25)

  • A Luca et al.

    TIPS for prevention of recurrent bleeding in patients with cirrhosis: meta-analysis of randomized clinical trials

    Radiology

    (1999)
  • AS Rosemurgy et al.

    A prospective trial of transjugular intrahepatic portosystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices

    Ann Surg

    (1996)
  • Cited by (0)

    *

    Reprint requests: J. Michael Henderson, MD, The Cleveland Clinic Foundation, 9500 Euclid Ave, A80, Cleveland, OH 44119.

    **

    Surgery 2000;128:540-7

    View full text